Key Points
-
Protein phosphatases have long been regarded as working in the background while kinases assume the important role of protein phosphorylation. This view has gradually changed with the realization that phosphatases are actively involved in the control of many cellular processes. In the nervous system, the involvement of protein phosphatases in synaptic plasticity has been extensively studied and constitutes the central topic of this article.
-
The three best characterized serine/threonine phosphatases in brain are protein phosphatase 1 (PP1), protein phosphatase 2A (PP2A) and calcineurin (PP2B). Each of these is present in the hippocampus, although their precise patterns of expression show some variation.
-
The activity of protein phosphatases is tightly regulated. Several regulatory mechanisms have been described, and they include the phosphorylation of regulatory subunits, the direct regulation of phosphatase activity by calcium, and their regulation by alterations in the subcellular localization of phosphatase and/or substrate. Neurons have taken advantage of this diversity by using phosphatases to trigger and maintain long-lasting changes in synaptic efficacy.
-
A cAMP-dependent protein kinase (PKA)-dependent suppression of PP1 activity seems to participate in the induction of long-term potentiation (LTP). This suppression depends on the phosphorylation of an endogenous phosphatase inhibitor. Similarly, PP2B appears to constrain LTP induction in CA1, as indicated by extensive pharmacological and genetic evidence. Moreover, a persistent downregulation of PP2A activity might be involved in the maintenance of LTP.
-
There is abundant pharmacological, genetic and biochemical evidence for the involvement of PP1/PP2A and/or PP2B activation in the induction of long-term depression (LTD). In addition, phosphatases are also involved in depotentiation — the reversal of LTP. However, the mechanisms involved in depotentiation might not necessarily be the same as those used during LTD induction; in the former, phosphatases might have to dephosphorylate specific substrates originally affected by LTP induction.
-
α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor subunits have been identified as prime targets of phosphatase action in neurons. So, dephosphorylation of AMPA receptors can modulate channel properties and their availability on the cell membrane. Similarly, phosphatases can regulate cytoskeletal elements and therefore affect synaptic remodelling. The regulation of phosphatase activity can also have longer-lasting effects on synaptic function through the dephosphorylation of transcription factors, and so the control of gene expression.
Abstract
The regulation of glutamate-mediated excitatory neurotransmission has a critical role in many aspects of behaviour. Great effort has gone into understanding the signal transduction cascades and effectors recruited in these processes, and protein phosphorylation has been identified as an important element. Although initial research in the field focused on the activity-dependent activation of kinases and the kinase dependence of various forms of synaptic plasticity, it has become increasingly clear that phosphatases have an equally dynamic and critical role in the activity-dependent alterations of synaptic transmission. Here, we review the roles of serine/threonine phosphatases in synaptic plasticity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kasahara, J., Fukunaga, K. & Miyamoto, E. Differential effects of a calcineurin inhibitor on glutamate-induced phosphorylation of Ca2+/calmodulin-dependent protein kinases in cultured rat hippocampal neurons. J. Biol. Chem. 274, 9061–9067 (1999).
Strack, S., Barban, M. A., Wadzinski, B. E. & Colbran, R. J. Differential inactivation of postsynaptic density-associated and soluble Ca2+/calmodulin-dependent protein kinase II by protein phosphatases 1 and 2A. J. Neurochem. 68, 2119–2128 (1997).
Rusnak, F. & Mertz, P. Calcineurin: form and function. Physiol. Rev. 80, 1483–1521 (2000).
Price, N. E. & Mumby, M. C. Brain protein serine/threonine phosphatases. Curr. Opin. Neurobiol. 9, 336–342 (1999).
Janssens, V. & Goris, J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353, 417–439 (2001).
Aggen, J. B., Nairn, A. C. & Chamberlin, R. Regulation of protein phosphatase-1. Chem. Biol. 7, R13–23 (2000).
Sontag, E. Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell. Signal. 13, 7–16 (2001).
Strack, S., Kini, S., Ebner, F. F., Wadzinski, B. E. & Colbran, R. J. Differential cellular and subcellular localization of protein phosphatase 1 isoforms in brain. J. Comp. Neurol. 413, 373–384 (1999).
Strack, S., Zaucha, J. A., Ebner, F. F., Colbran, R. J. & Wadzinski, B. E. Brain protein phosphatase 2A: developmental regulation and distinct cellular and subcellular localization by B subunits. J. Comp. Neurol. 392, 515–527 (1998).
Steiner, J. P. et al. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature 358, 584–587 (1992).
Morioka, M., Nagahiro, S., Fukunaga, K., Miyamoto, E. & Ushio, Y. Calcineurin in the adult rat hippocampus: different distribution in CA1 and CA3 subfields. Neuroscience 78, 673–684 (1997).
Halpain, S., Hipolito, A. & Saffer, L. Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J. Neurosci. 18, 9835–9844 (1998).
Sik, A., Hajos, N., Gulacsi, A., Mody, I. & Freund, T. F. The absence of a major Ca2+ signaling pathway in GABAergic neurons of the hippocampus. Proc. Natl Acad. Sci. USA 95, 3245–3250 (1998).
Huang, F. L. & Glinsmann, W. H. Inactivation of rabbit muscle phosphorylase phosphatase by cyclic AMP-dependent kinase. Proc. Natl Acad. Sci. USA 72, 3004–3008 (1975).
Nimmo, G. A. & Cohen, P. The regulation of glycogen metabolism: purification and characterisation of protein phosphatase inhibitor-1 from rabbit skeletal muscle. Eur. J. Biochem. 87, 341–351 (1978).
Walaas, S. I., Aswad, D. W. & Greengard, P. A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 301, 69–71 (1983).
Sakagami, H., Ebina, K. & Kondo, H. Localization of phosphatase inhibitor-1 mRNA in the developing and adult rat brain in comparison with that of protein phosphatase-1 mRNAs. Brain Res. Mol. Brain Res. 25, 7–18 (1994).
Blitzer, R. D. et al. Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP. Science 280, 1940–1943 (1998).An example of how complex regulatory mechanisms govern phosphorylation and dephosphorylation in the induction of LTP.
Allen, P. B. et al. Protein phosphatase-1 regulation in the induction of long-term potentiation: heterogeneous molecular mechanisms. J. Neurosci. 20, 3537–3543 (2000).
Gustafson, E. L., Girault, J. A., Hemmings, H. C. Jr., Nairn, A. C. & Greengard, P. Immunocytochemical localization of phosphatase inhibitor-1 in rat brain. J. Comp. Neurol. 310, 170–188 (1991).
Lin, J. W. et al. Yotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1. J. Neurosci. 18, 2017–2027 (1998).
Westphal, R. S. et al. Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science 285, 93–96 (1999).An illustration of the role of postsynaptic supramolecular complexes in the regulation of receptor function.
Allen, P. B., Ouimet, C. C. & Greengard, P. Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc. Natl Acad. Sci. USA 94, 9956–9961 (1997).
Smith, F. D., Oxford, G. S. & Milgram, S. L. Association of the D2 dopamine receptor third cytoplasmic loop with spinophilin, a protein phosphatase-1-interacting protein. J. Biol. Chem. 274, 19894–19900 (1999).
Richman, J. G. et al. Agonist-regulated interaction between α2-adrenergic receptors and spinophilin. J. Biol. Chem. 276, 15003–15008 (2001).
Burnett, P. E. et al. Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton. Proc. Natl Acad. Sci. USA 95, 8351–8356 (1998).
Feng, J. et al. Spinophilin regulates the formation and function of dendritic spines. Proc. Natl Acad. Sci. USA 97, 9287–9292 (2000).
Yan, Z. et al. Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP-32 and spinophilin. Nature Neurosci. 2, 13–17 (1999).
Nakanishi, H. et al. Neurabin: a novel neural tissue-specific actin filament-binding protein involved in neurite formation. J. Cell Biol. 139, 951–961 (1997).
McAvoy, T. et al. Regulation of neurabin I interaction with protein phosphatase 1 by phosphorylation. Biochemistry 38, 12943–12949 (1999).
MacMillan, L. B. et al. Brain actin-associated protein phosphatase 1 holoenzymes containing spinophilin, neurabin, and selected catalytic subunit isoforms. J. Biol. Chem. 274, 35845–35854 (1999).
Beullens, M., Van Eynde, A., Stalmans, W. & Bollen, M. The isolation of novel inhibitory polypeptides of protein phosphatase 1 from bovine thymus nuclei. J. Biol. Chem. 267, 16538–16544 (1992).
Jagiello, I. et al. NIPP-1, a nuclear inhibitory subunit of protein phosphatase-1, has RNA-binding properties. J. Biol. Chem. 272, 22067–22071 (1997).
Beullens, M., Van Eynde, A., Bollen, M. & Stalmans, W. Inactivation of nuclear inhibitory polypeptides of protein phosphatase-1 (NIPP-1) by protein kinase A. J. Biol. Chem. 268, 13172–13177 (1993).
Klee, C. B., Ren, H. & Wang, X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J. Biol. Chem. 273, 13367–13370 (1998).
Bito, H., Deisseroth, K. & Tsien, R. W. CREB phosphorylation and dephosphorylation: a Ca2+- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87, 1203–1214 (1996).Demonstrates that, as with LTP, complex mechanisms govern the regulation of transcription factor activation and inactivation by activity-evoked phosphorylation, and dephosphorylation.
Lai, M. M., Burnett, P. E., Wolosker, H., Blackshaw, S. & Snyder, S. H. Cain, a novel physiologic protein inhibitor of calcineurin. J. Biol. Chem. 273, 18325–18331 (1998).
Sun, L. et al. Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. Immunity 8, 703–711 (1998).
Coghlan, V. M. et al. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 267, 108–111 (1995).
Snyder, S. H., Lai, M. M. & Burnett, P. E. Immunophilins in the nervous system. Neuron 21, 283–294 (1998).
Genazzani, A. A., Carafoli, E. & Guerini, D. Calcineurin controls inositol 1,4,5-trisphosphate type 1 receptor expression in neurons. Proc. Natl Acad. Sci. USA 96, 5797–5801 (1999).
Lai, M. M., Luo, H. R., Burnett, P. E., Hong, J. J. & Snyder, S. H. The calcineurin-binding protein cain is a negative regulator of synaptic vesicle endocytosis. J. Biol. Chem. 275, 34017–34020 (2000).
Colledge, M. et al. Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex. Neuron 27, 107–119 (2000).
Blitzer, R. D., Wong, T., Nouranifar, R., Iyengar, R. & Landau, E. M. Postsynaptic cAMP pathway gates early LTP in hippocampal CA1 region. Neuron 15, 1403–1114 (1995).
Winder, D. G., Mansuy, I. M., Osman, M., Moallem, T. M. & Kandel, E. R. Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell 92, 25–37 (1998).References 45, 51, 56, 57 and 59 represent the first genetic studies aimed at the determination of the roles of serine/threonine phosphatases in hippocampal plasticity, learning and memory.
Abel, T. et al. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 88, 615–626 (1997).
Huang, Y. Y., Nguyen, P. V., Abel, T. & Kandel, E. R. Long-lasting forms of synaptic potentiation in the mammalian hippocampus. Learn. Mem. 3, 74–85 (1996).
Thomas, M. J., Moody, T. D., Makhinson, M. & O'Dell, T. J. Activity-dependent β-adrenergic modulation of low frequency stimulation induced LTP in the hippocampal CA1 region. Neuron 17, 475–482 (1996).
Brown, G. P. et al. Long-term potentiation induced by theta frequency stimulation is regulated by a protein phosphatase-1-operated gate. J. Neurosci. 20, 7880–7887 (2000).
Makhinson, M., Chotiner, J. K., Watson, J. B. & O'Dell, T. J. Adenylyl cyclase activation modulates activity-dependent changes in synaptic strength and Ca2+/calmodulin-dependent kinase II autophosphorylation. J. Neurosci. 19, 2500–2510 (1999).
Ikegami, S. et al. A facilitatory effect on the induction of long-term potentiation in vivo by chronic administration of antisense oligodeoxynucleotides against catalytic subunits of calcineurin. Brain Res. Mol. Brain Res. 41, 183–191 (1996).
Wang, J. H. & Kelly, P. T. The balance between postsynaptic Ca2+-dependent protein kinase and phosphatase activities controlling synaptic strength. Learn. Mem. 3, 170–181 (1996).
Lu, Y. F. et al. Calcineurin inhibitors, FK506 and cyclosporin A, suppress the NMDA receptor-mediated potentials and LTP, but not depotentiation in the rat hippocampus. Brain Res. 729, 142–146 (1996).
Wang, J. H. & Stelzer, A. Inhibition of phosphatase 2B prevents expression of hippocampal long-term potentiation. Neuroreport 5, 2377–2380 (1994).
Bennett, P. C., Singaretnam, L. G., Zhao, W. Q., Lawen, A. & Ng, K. T. Peptidyl-prolyl-cis/trans-isomerase activity may be necessary for memory formation. FEBS Lett. 431, 386–390 (1998).
Malleret, G. et al. Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell 104, 675–686 (2001).
Mansuy, I. M. et al. Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron 21, 257–265 (1998).
Ikegami, S. & Inokuchi, K. Antisense DNA against calcineurin facilitates memory in contextual fear conditioning by lowering the threshold for hippocampal long-term potentiation induction. Neuroscience 98, 637–646 (2000).
Mansuy, I. M., Mayford, M., Jacob, B., Kandel, E. R. & Bach, M. E. Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell 92, 39–49 (1998).
Figurov, A., Boddeke, H. & Muller, D. Enhancement of AMPA-mediated synaptic transmission by the protein phosphatase inhibitor calyculin A in rat hippocampal slices. Eur. J. Neurosci. 5, 1035–1041 (1993).
Norris, C. M., Halpain, S. & Foster, T. C. Alterations in the balance of protein kinase/phosphatase activities parallel reduced synaptic strength during aging. J. Neurophysiol. 80, 1567–1570 (1998).
Wang, J. H. & Kelly, P. T. Postsynaptic calcineurin activity downregulates synaptic transmission by weakening intracellular Ca2+ signaling mechanisms in hippocampal CA1 neurons. J. Neurosci. 17, 4600–4611 (1997).
Lu, Y. M., Mansuy, I. M., Kandel, E. R. & Roder, J. Calcineurin-mediated LTD of GABAergic inhibition underlies the increased excitability of CA1 neurons associated with LTP. Neuron 26, 197–205 (2000).
Fukunaga, K. et al. Decreased protein phosphatase 2A activity in hippocampal long-term potentiation. J. NeuroChem. 74, 807–817 (2000).References 64 and 75 are two of the few studies directly assessing protein phosphatase activity in synaptic plasticity.
Strack, S., Choi, S., Lovinger, D. M. & Colbran, R. J. Translocation of autophosphorylated calcium/calmodulin-dependent protein kinase II to the postsynaptic density. J. Biol. Chem. 272, 13467–13470 (1997).A very interesting study showing that subcellular localization, determined by phosphorylation state, dictates the type of phosphatase that can dephosphorylate proteins critical for LTP induction.
Westphal, R. S., Anderson, K. A., Means, A. R. & Wadzinski, B. E. A signaling complex of Ca2+-calmodulin-dependent protein kinase IV and protein phosphatase 2A. Science 280, 1258–1261 (1998).
Roberson, E. D. & Sweatt, J. D. Transient activation of cyclic AMP-dependent protein kinase during hippocampal long-term potentiation. J. Biol. Chem. 271, 30436–30441 (1996).
Lisman, J. A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory. Proc. Natl Acad. Sci. USA 86, 9574–9578 (1989).
Lisman, J. The CaM kinase II hypothesis for the storage of synaptic memory. Trends Neurosci. 17, 406–412 (1994).
Mulkey, R. M., Herron, C. E. & Malenka, R. C. An essential role for protein phosphatases in hippocampal long-term depression. Science 261, 1051–1055 (1993).
Ramakers, G. M., Heinen, K., Gispen, W. H. & de Graan, P. N. Long term depression in the CA1 field is associated with a transient decrease in pre- and postsynaptic PKC substrate phosphorylation. J. Biol. Chem. 275, 28682–28687 (2000).
Lee, H. K., Barbarosie, M., Kameyama, K., Bear, M. F. & Huganir, R. L. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405, 955–959 (2000).A ground-breaking study of the bimodal regulation of AMPA receptor phosphorylation and dephosphorylation, illustrating the complexities of these mechanisms in LTP, LTD and depotentiation.
Norman, E. D., Thiels, E., Barrionuevo, G. & Klann, E. Long-term depression in the hippocampus in vivo is associated with protein phosphatase-dependent alterations in extracellular signal-regulated kinase. J. NeuroChem. 74, 192–198 (2000).
Thiels, E., Kanterewicz, B. I., Knapp, L. T., Barrionuevo, G. & Klann, E. Protein phosphatase-mediated regulation of protein kinase C during long-term depression in the adult hippocampus in vivo. J. Neurosci. 20, 7199–7207 (2000).
Thiels, E., Norman, E. D., Barrionuevo, G. & Klann, E. Transient and persistent increases in protein phosphatase activity during long-term depression in the adult hippocampus in vivo. Neuroscience 86, 1023–1029 (1998).
Coussens, C. M. & Teyler, T. J. Protein kinase and phosphatase activity regulate the form of synaptic plasticity expressed. Synapse 24, 97–103 (1996).
Herron, C. E. & Malenka, R. C. Activity-dependent enhancement of synaptic transmission in hippocampal slices treated with the phosphatase inhibitor calyculin A. J. Neurosci. 14, 6013–6020 (1994).
Kameyama, K., Lee, H.-K., Bear, M. F. & Huganir, R. L. Involvement of a postsynaptic protein kinase A substrate in the expression of homosynaptic long-term depression. Neuron 21, 1163–1175 (1998).
Oliet, S. H., Malenka, R. C. & Nicoll, R. A. Two distinct forms of long-term depression coexist in CA1 hippocampal pyramidal cells. Neuron 18, 969–982 (1997).
Muller, D., Hefft, S. & Figurov, A. Heterosynaptic interactions between LTP and LTD in CA1 hippocampal slices. Neuron 14, 599–605 (1995).
Mulkey, R. M., Endo, S., Shenolikar, S. & Malenka, R. C. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 369, 486–488 (1994).
Kamal, A., Ramakers, G. M., Urban, I. J., De Graan, P. N. & Gispen, W. H. Chemical LTD in the CA1 field of the hippocampus from young and mature rats. Eur. J. Neurosci. 11, 3512–3516 (1999).
Zhuo, M. et al. A selective role of calcineurin Aα in synaptic depotentiation in hippocampus. Proc. Natl Acad. Sci. USA 96, 4650–4655 (1999).
Lee, H. K., Kameyama, K., Huganir, R. L. & Bear, M. F. NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus. Neuron 21, 1151–1162 (1998).
Sweatt, J. D. et al. Protected-site phosphorylation of protein kinase C in hippocampal long-term potentiation. J. NeuroChem. 71, 1075–1085 (1998).
Carroll, R. C., Beattie, E. C., von Zastrow, M. & Malenka, R. C. Role of AMPA receptor endocytosis in synaptic plasticity. Nature Rev. Neurosci. 2, 315–324 (2001).
Ehlers, M. D. Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron 28, 511–525 (2000).
Beattie, E. C. et al. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nature Neurosci. 3, 1291–1300 (2000).
Lin, J. W. et al. Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization. Nature Neurosci. 3, 1282–1290 (2000).
Lai, M. M. et al. The calcineurin-dynamin 1 complex as a calcium sensor for synaptic vesicle endocytosis. J. Biol. Chem. 274, 25963–25966 (1999).
Krucker, T., Siggins, G. R. & Halpain, S. Dynamic actin filaments are required for stable long-term potentiation (LTP) in area CA1 of the hippocampus. Proc. Natl Acad. Sci. USA 97, 6856–6861 (2000).
Kim, C. H. & Lisman, J. E. A role of actin filament in synaptic transmission and long-term potentiation. J. Neurosci. 19, 4314–4324 (1999).
Graef, I. A. et al. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 401, 703–708 (1999).
Banke, T. G. et al. Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J. Neurosci. 20, 89–102 (2000).
Traynelis, S. F. & Wahl, P. Control of rat GluR6 glutamate receptor open probability by protein kinase A and calcineurin. J. Physiol. 503, 513–531 (1997).
Tong, G., Shepherd, D. & Jahr, C. E. Synaptic desensitization of NMDA receptors by calcineurin. Science 267, 1510–1512 (1995).
Jones, M. V. & Westbrook, G. L. Shaping of IPSCs by endogenous calcineurin activity. J. Neurosci. 17, 7626–7633 (1997).
Gereau, R. W. & Heinemann, S. F. Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor 5. Neuron 20, 143–151 (1998).
Gereau, R. W. & Conn, P. J. Roles of specific metabotropic glutamate receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability. J. Neurophysiol. 74, 122–129 (1995).
Alagarsamy, S. et al. Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems. Nature Neurosci. 2, 234–240 (1999).
Alagarsamy, S., Gereau, R. W., Mansuy, I., Warren, L. & Conn, P. J. NMDA-induced reversal of mGluR5 desensitization is mediated by activation of protein phosphatase 2B/calcineurin. Soc. Neurosci. Abstr. 26, 910 (2000).
Paterson, J. M. et al. Characterisation of human adenylyl cyclase IX reveals inhibition by Ca2+/calcineurin and differential mRNA polyadenylation. J. NeuroChem. 75, 1358–1367 (2000).
Antoni, F. A. et al. Ca2+/calcineurin-inhibited adenylyl cyclase, highly abundant in forebrain regions, is important for learning and memory. J. Neurosci. 18, 9650–9661 (1998).
Paterson, J. M., Smith, S. M., Harmar, A. J. & Antoni, F. A. Control of a novel adenylyl cyclase by calcineurin. Biochem. Biophys. Res. Commun. 214, 1000–1008 (1995).
Runden, E. et al. Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J. Neurosci. 18, 7296–7305 (1998).
O'Dell, T. J. & Kandel, E. R. Low-frequency stimulation erases LTP through an NMDA receptor-mediated activation of protein phosphatases. Learn. Mem. 1, 129–139 (1994).
Davis, S., Vanhoutte, P., Pages, C., Caboche, J. & Laroche, S. The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J. Neurosci. 20, 4563–4572 (2000).
Qian, Z., Gilbert, M. & Kandel, E. R. Temporal and spatial regulation of the expression of BAD2, a MAP kinase phosphatase, during seizure, kindling, and long-term potentiation. Learn. Mem. 1, 180–188 (1994).
Sgambato, V., Pages, C., Rogard, M., Besson, M.-J. & Caboche, J. Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J. Neurosci. 18, 8814–8825 (1998).
Acknowledgements
We thank R. Colbran, C. Weitlauf and A. Vanhoose for critically reading the manuscript.
Author information
Authors and Affiliations
Related links
Glossary
- OKADAIC ACID
-
A polyether fatty acid isolated from the dinoflagellate Prorocentrum lima and used as a potent inhibitor of protein phosphatases, especially types 1 and 2A.
- CALYCULIN A
-
A metabolite of the Japanese marine sponge Discodermia calyx that has strong antitumour activity. It is a potent inhibitor of protein phosphatase types 1 and 2A.
- MICROCYSTINS
-
Cyclic heptapeptide toxins produced by cyanobacteria. They are potent inhibitors of protein phosphatases 1 and 2A.
- FK506
-
A member of the macrolide antibiotic family isolated from Streptomyces tsukubaensis. It binds to FK506-binding proteins (FKBPs) and serves as an immunosuppressant. In a complex with FKBPs, it can block the action of calcineurin.
- CYCLOSPORIN A
-
A cyclic decapeptide isolated from the fungi Cylindrocarpon lucidum and Tolypocladium inflatum that serves as a potent immunosuppressive. When bound to cyclophilin, it can bind and inactivate calcineurin.
- IMMUNOPHILIN
-
A generic term for proteins that can bind immunosuppressive drugs.
- PDZ DOMAIN
-
peptide-binding domain that is important for the organization of membrane proteins, particularly at cell–cell junctions, including synapses. They can bind to the carboxyl termini of proteins, or can form dimers with other PDZ domains. PDZ domains are named after the proteins in which these sequence motifs were originally identified (PSD95, Discs-large, zona occludens-1).
- SCHAFFER COLLATERALS
-
Axons of the CA3 pyramidal cells of the hippocampus that form synapses with the apical dendrites of CA1 neurons.
- REVERSE TETRACYCLINE-DEPENDENT TRANSACTIVATOR SYSTEM
-
A system that allows the precise control of gene expression in eukaryotic systems through the administration of tetracycline or its analogues, for example, doxycycline. It is based on two key elements: a mutant form of the tetracycline-dependent transactivator protein (tTA) and the target gene under the control of a tTA-responsive element. Once these key elements have been transferred into eukaryotic cells, the mutant tTA is expressed, but does not bind the tTA-responsive element. Binding of the mutant tTA to the tTA-responsive element and initiation of transcription is then induced by the addition of tetracycline.
- SILENT SYNAPSE
-
A synapse that contains NMDA receptors but no AMPA receptors and therefore is functionally silent during low-frequency, basal synaptic transmission.
- CLATHRIN
-
A major structural component of coated vesicles that are implicated in protein transport. Clathrin heavy and light chains form a triskelion, the main building element of clathrin coats.
- DYNAMIN
-
A small GTPase that is involved in endocytosis. It is thought to be involved in severing the connection between the nascent vesicle and the donor membrane.
- MORRIS WATER MAZE
-
A learning task in which an animal is placed in a pool filled with opaque water and has to learn to escape to a hidden platform that is placed at a constant position. The animal must learn to use distal cues, and the spatial relationship between them and the position of the platform. Learning in this task involves the hippocampus.
- BARNES MAZE
-
A learning task in which the animal is placed on a large, open table that has holes in the periphery. Only one of the holes has an escape tunnel, and the animal must learn to use distal cues to identify this hole and escape in the shortest possible time. Learning in this task involves the hippocampus.
Rights and permissions
About this article
Cite this article
Winder, D., Sweatt, J. Roles of serine/threonine phosphatases in hippocampel synaptic plasticity. Nat Rev Neurosci 2, 461–474 (2001). https://doi.org/10.1038/35081514
Issue Date:
DOI: https://doi.org/10.1038/35081514
This article is cited by
-
Blockade of Type 2A Protein Phosphatase Signaling Attenuates Complement C1q-Mediated Microglial Phagocytosis of Glutamatergic Synapses Induced by Amyloid Fibrils
Molecular Neurobiology (2023)
-
Involvement of the Voltage-Gated Calcium Channels L- P/Q- and N-Types in Synapse Elimination During Neuromuscular Junction Development
Molecular Neurobiology (2022)
-
Calbindin regulates Kv4.1 trafficking and excitability in dentate granule cells via CaMKII-dependent phosphorylation
Experimental & Molecular Medicine (2021)
-
Treatment with the calcineurin inhibitor and immunosuppressant cyclosporine A impairs sensorimotor gating in Dark Agouti rats
Psychopharmacology (2021)
-
Yy1 regulates Senp1 contributing to AMPA receptor GluR1 expression following neuronal depolarization
Journal of Biomedical Science (2019)